HomeNewsBusinessAny port in a storm: India may benefit from Sri Lanka’s problems

Any port in a storm: India may benefit from Sri Lanka’s problems

The government expects trouble at Colombo port to push traffic at Indian ports by around 50,000 TEUs in April-June.

April 13, 2022 / 20:08 IST
Story continues below Advertisement
Representative Image
Representative Image

The political and economic uncertainties in Sri Lanka and congestion at Colombo Port, that country’s biggest and busiest, are expected to force more ships to turn to Indian ports in the first quarter of 2022-23, senior government officials said.

Officials said initial estimates suggest around 50,000 twenty-foot equivalent units (TEUs) of cargo are expected to expected to be diverted to Indian ports in April-June.

Story continues below Advertisement

TEU is a measure of capacity of a container port.

“Our estimates suggest that Chennai Port, V.O. Chidambaranar Port (in Thoothukudi, Tamil Nadu) and Cochin Port will see increased traffic for at least the next three months. The initial study says that 50,000 TEU more cargo traffic will be diverted to these ports in the next three months,” a senior government official said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show